$NBIS

Boroditsky Marc sold $5.5M of NBIS

Boroditsky Marc (Chief Revenue Officer) sold 26,886 shares of Nebius Group N.V. (NBIS) at an average of $205.87 ($197.00–$250.00, $5.54M total) across 2 trades over 2026-06-15 to 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Boroditsky Marc
Published Sep 21, 2026, 9:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 9:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Neutral
medium confidence
Mentioned
$NBIS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISNeutralLow
01

Why it matters

The sale reduces insider ownership to zero, but the transaction size is modest.

02

Market read

A routine insider sale with limited market impact.

03

What to watch

Potential upcoming corporate actions or financing that prompted the sale.

Relevance 5/10Novelty 3/10Timing: today

Background

Form 4 filing provides the first public disclosure of the insider's share sale.

Company-level read

Ticker impact

$NBISNeutralMedium confidence
Context

Chief Revenue Officer sold 26,886 shares for $5.5M via 10b5-1 plan, reducing holdings to zero.

Expected impact

Potential short-term downward pressure, likely limited.

Evidence & confidence

Sale amount is small relative to market cap; market may react minimally.

Market effects

Minimal impact on the broader tech/communications sector.

Limited effect on European microcap markets.

Low relevance globally.

Counterpoint

Insider could be cashing out for personal reasons; not necessarily negative for the company.

Key entities

  • Nebius Group N.V.

    Issuer of the shares sold.

  • Marc Boroditsky

    Chief Revenue Officer and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.